Background -Streptococcus milleri is increasingly being recognised as an important pulmonary pathogen which may lead to the development of empyema or lung abscess. Although several small series have been reported, the clinical and laboratory features have yet to be fully characterised. Methods -Twenty five cases were identified and the clinical and laboratory data from case records were analysed. Results -There were 16 empyemas, five lung abscesses, and four with both lung abscess and empyema. The mean age of the patients was 61 years (range 36-89) and 84% were men. The most common symptoms at presentation were shortness of breath, chest pain, cough, and weight loss; only 36% had a fever. Four of the nine patients with lung abscess required a diagnostic lobectomy because ofsuspected malignancy. Predisposing factors were present in 80% of patients and included the following: pneumonia, periodontal disease, excess alcohol intake, previous thoracic surgical procedures, and malignancy. Laboratory features of S milleri infection were leucocytosis, neutrophilia, anaemia, abnormal liver function tests, and hypoalbuminaemia. In the group with empyema five patients had a pneumothorax on initial presentation and pleural loculation occurred in 10 of these patients. The median stay in hospital was 34 days (range 11-88). Six patients died, five of whom had significant underlying illnesses. Conclusions -Pulmonary infection with S milleri may result in considerable morbidity and mortality, and is characterised by a strong male predominance, non-specific symptoms (often without toxicity), the presence of predisposing factors, pleural loculation, pneumothorax, and a protracted stay in hospital.
The term "Streptococcus milleri group" refers to a heterogeneous group of streptococci which is increasingly being recognised as a group of clinically important pathogens. The classification of these organisms has been the subject of considerable debate with the emergence of British and American systems.' The British system2 groups the organisms into one species, Streptococcus milleri, while the American system'3 separates them into distinct species (Streptococcus anginosis, Streptococcus constellatus, Streptococcus intermedius). Two more recent modifications ofthese systems have been described -one4 supports a single species (Streptococcus anginosis) and the other56 supports a separation into three species. Despite these taxonomic differences, the term "Streptococcus miller?' has persisted and is widely used in the clinical setting. Two other terms -"viridans streptococci" (which includes other streptococcal species) and "microaerophilic streptococci" -are also used by a number of laboratories to refer to Streptococcus milleri but do not identify the organisms to a species level.
Streptococcus milleri is a widely distributed commensal which is normally found in the mouth, upper respiratory tract, gastrointestinal tract, and vagina.7 Various pyogenic infections have been attributed to this pathogen which has a striking predilection for abscess formation. It is a recognised cause of brain, dental, lung, liver, subphrenic, pelvic, and subcutaneous abscesses, as well as abscesses in other sites. It may also cause empyema, meningitis, osteomyelitis, peritonitis, and endocarditis. 8"12 There are a number of reports documenting the importance of S milleri in the development of empyema and lung abscess. However, only five small series describe the clinical features in these patients. Shlaes et al found six cases of empyema (three associated with lung abscess) and one case of lung abscess alone over a 10 year period.9 A series from New Zealand reported four cases ofempyema in six months. 3 Hocken and Dussek'4 reported six cases of empyema in a consecutive series of 25 patients in one year and Ferber et all5 found 11 patients with empyema in one year and described six cases. Another more recent series from Japan described 10 cases of empyema over a five year period. '6 We report the characteristics of 25 patients with S milleri infection associated with empyema or lung abscess.
Methods
Twenty five patients with empyema and/or lung abscess due to S milleri are described. Twenty two cases were identified from the microbiology department computer records of all S milleri specimens from two 1400 bed general hospitals (City and University Hospitals, Nottingham) between October 1991 and September 1994. Three additional patients identified before this period were included in the analysis. Specimens were obtained by thoracocentesis, thora- The median duration of symptoms in 24 of the patients was 18 days (mean 61; range 1-300). In addition, one patient (no. 6) had protracted symptoms (730 days) because of difficulty in establishing a diagnosis, and subsequently died. Nine patients had symptoms for more than three months before presentation and only five patients had symptoms for less than one week. The most common symptoms at the time of presentation were shortness of breath (76%), chest pain (72%), cough (64%), and weight loss (40%). Other symptoms included fever (28%), sweats (16%), haemoptysis (12%), and rigors (4%). Twenty patients were cigarette smokers.
Only nine patients had a fever at presentation of >37-5°C; however, 20 patients had a fever of >37 5°C during the admission. Clubbing was found in eight patients.
Community acquired pneumonia was associated with the development of empyema or lung abscess in 10 patients (table 1) . Dental caries and periodontal disease was noted in four patients; in the other patients this information was not available. Three had a history of excessive alcohol intake. Three patients had previously had thoracic surgical procedures, one patient had a perforated oesophagus which was treated conservatively, and one had a subphrenic abscess. Three patients had carcinomas (two lung, one bladder), two patients had diabetes mellitus, and one had a dense hemiplegia associated with a stroke. One patient was taking oral corticosteroids and no patients were taking other immunosuppressive medications. Overall, a predisposing factor was present in 20 patients.
Streptococcus milleri was grown from pleural fluid (19) , resected lung (four), postmortem pleural fluid and lung (one), and lung aspirate (one) in pure culture in 16 of the 25 patients and anaerobic organisms were also cultured in six patients (table 1) . Sputum cultures were obtained in 21 patients and S milleri was cultured from only one specimen (pleural fluid positive also). One patient with empyema also The median duration of stay in hospital for the 19 surviving patients was 34 days (mean 41; range 11-88). Three patients (nos 7, 15, 20) were admitted to the intensive care unit for 24, 35, and nine days respectively. Ofthe six patients tho died, five had underlying illnesses (two lung cancer), one diabetes, one stroke, one rheumatoid arthritis. Patient no. 2 was diagnosed at necropsy and received no specific treatment. All of the deaths were directly attributed to the underlying S milleri infection. There was no relationship between death and the clinical, laboratory, or radiological features.
Discussion
Pulmonary infection with S milleri in our series was characterised by a male predominance, leucocytosis, abnormal liver function tests, pleural loculation, a high incidence of pneumothorax, and a protracted stay in hospital. Previous reports have noted the presence of severe toxic symptoms and rapid onset and progression, but these features were not prominent in our cases and the disease was often indolent."'7 In four of the nine patients with lung abscess lung resection was performed because malignancy was suspected, and none of these patients had toxic symptoms or fever on presentation.
Predisposing factors which have been associated with S milleri empyema and lung abscess include mucosal disturbance (sinusitis, periodontal disease, enteric disease such as oesophageal perforation), preceding pneumonia, thoracic surgery, malignancy, neurological disease, alcohol abuse, and diabetes.9""-' In our series predisposing factors were present in 80% of cases, with pneumonia occurring in 40% ofthe empyemas and thoracic surgery in 15%. This compares with 67% in an extensive review of S milleri infections at any site.'2 In empyema caused by other organisms, pneumonia accounted for about 50% of cases and another 25% were due to thoracic or gastro-oesophageal surgery.'819
Pure culture occurs in 30-83% of patients with S milleri pleuropulmonary infection and mixed culture with anaerobes in 17-60%.911 13"16 20S 
